ArticleJournal for immunotherapy of cancer2023

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.

Vincenzo Nasca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.